DEF 14A: Reliance Global Group Seeks Stockholder Approval for Increased Authorized Shares and New Incentive Plan
Proxy Statement
Reliance Global Group is holding a virtual annual meeting on December 16, 2024, to vote on key proposals including increasing authorized shares of common stock and approving a new omnibus incentive plan.
Summary
- Reliance Global Group, Inc. is convening a virtual Annual Meeting of Stockholders on December 16, 2024.
- Stockholders will vote on five proposals: electing five directors, approving the 2024 Omnibus Incentive Plan, increasing authorized common stock, ratifying the appointment of Urish Popeck & Co., LLC as the independent auditor, and transacting other business.
- The board recommends voting FOR all proposals.
- The proposal to increase authorized shares seeks to raise the total from 117,647,058 to 2,000,000,000 shares.
- The 2024 Omnibus Incentive Plan proposes authorizing 1,000,000 shares for issuance under the plan.
- The record date for determining stockholders eligible to vote is October 17, 2024.
- The proxy materials were distributed on or about October 31, 2024.
Sentiment
Score: 7
Explanation: The document is generally positive, focusing on governance matters and future flexibility. However, the past reporting failures and underperformance temper the overall sentiment.
Positives
- The proposed increase in authorized shares provides the company with greater flexibility for future corporate needs, including financings and strategic transactions.
- The 2024 Omnibus Incentive Plan is designed to attract and retain key personnel and align their interests with those of the company's stockholders.
- The board of directors is actively engaged in risk oversight and has established committees to address audit, governance, and compensation matters.
- The company has a Code of Ethics and Business Conduct applicable to all employees, officers, and directors.
Negatives
- Future issuance of additional authorized shares of common stock may dilute the earnings per share and the equity and voting rights of existing stockholders.
- Several executive officers and directors failed to timely file Form 4s reporting transactions in the company's securities during the fiscal year ended December 31, 2023.
- The company's cumulative TSR has significantly underperformed its peer group over the past three years.
Risks
- The company's ability to attract and retain key personnel could be affected if the 2024 Omnibus Incentive Plan is not approved.
- The company's stock price could be negatively impacted by the potential dilution from the issuance of additional authorized shares.
- The company's financial performance could be affected by its ability to achieve the performance goals set forth in the 2024 Omnibus Incentive Plan.
- The company faces the risk of non-compliance with Section 409A of the Code, which could result in additional taxes and penalties for participants.
Future Outlook
The company aims to leverage the increased authorized shares for future corporate needs and believes the incentive plan will attract and retain key personnel, driving long-term success.
Management Comments
- Ezra Beyman, Chairman of the Board and Chief Executive Officer, thanks stockholders for their support.
- The Board unanimously recommends that stockholders vote FOR all of the proposals presented.
Industry Context
The use of omnibus incentive plans is a common practice among publicly traded companies to attract and retain talent. Increasing authorized shares is often done to provide flexibility for future capital raising and strategic transactions.
Comparison to Industry Standards
- The size of the proposed equity incentive plan (1,000,000 shares) should be compared to similar companies in the insurance or financial services industry to assess its competitiveness.
- The director compensation structure, including cash fees and stock awards, should be benchmarked against peer companies to ensure it is aligned with market practices.
- The company's corporate governance practices, such as board independence and committee structure, should be evaluated against best practices and regulatory requirements.
- Comparable companies for benchmarking purposes could include other small-cap insurance brokers or financial services firms with similar revenue and market capitalization.
Stakeholder Impact
- Approval of the proposals could impact shareholders through potential dilution and the effectiveness of executive compensation.
- Employees may be affected by the approval of the 2024 Omnibus Incentive Plan.
- The company's future financial performance could be affected by its ability to attract and retain key personnel and execute its strategic plans.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold the virtual Annual Meeting of Stockholders on December 16, 2024.
- The company will announce the results of the voting in a Current Report on Form 8-K.
Key Dates
| Date | Description |
|---|---|
| October 17, 2024 | Record date for the 2024 Annual Meeting |
| October 31, 2024 | On or about this date, proxy materials will begin to be mailed |
| December 15, 2024 | Deadline for internet or telephonic proxy submission (11:59 p.m. Eastern Time) |
| December 16, 2024 | Virtual Annual Meeting of Stockholders at 1:00 p.m. Eastern Time |
| July 3, 2025 | Deadline for stockholder proposals for inclusion in the 2025 proxy materials |
Keywords
proxy statement, annual meeting, authorized shares, omnibus incentive plan, directors, executive compensation, stock options, restricted stock, corporate governance, Urish Popeck, ratification, independent auditor, Reliance Global Group
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.